Phillip Strett, a lawyer with Kilpatrick Stockton in Atlanta, is the new chair of the board of directors for the Southeast BIO organization.

Street replaces Rebecca Kaufman, who works at King & Spalding LLP.

"SEBIO is entering a phase of real growth as an organization, and I’m excited to oversee that as the incoming chair," Street said in a statement. "SEBIO has always been about supporting the growth of the life-sciences industry in the Southeast. The ongoing initiatives of SEBIO will heighten the national recognition of the Southeast as a center for the life-sciences industry."

Other board members include: Kathryne Carr, Tall Oaks Capital, vice chair; Jim Bongiorno, Ernst & Young, treasurer; Garheng Kong, Intersouth Partners, secretary.

Executive committee members include: Todd Brady, Domain Associates; Aaron Davidson, H.I.G. Ventures; David Day, University of Florida; Frank Hunt, SE bioStrategies, Inc.; Rebecca Kaufman, King & Spalding LLP; Rose Ritts, Duke University; Todd Sherer, Emory University; Ken Tindall, North Carolina Biotechnology Center; Max Wallace, TheraLogics, Inc.; and Miriam Wilson, SC Launch.

New board members include: William W. Brooke, Harbert Management Corp.; Susan Casey, Square One Bank; Leslie J. Croland, Edwards, Angell, Palmer & Dodge LLP; Aaron Davidson, H.I.G. Ventures; Scott Doron, Southern Technology Council/ Southern Growth Policies Board; Monica P. Doss, Council for Entrepreneurial Development; David R. Lohr, Virginia Biosciences Development Center; Christopher D. McKinney, Vanderbilt University; Peter Policastro, Scripps Florida; Rose Ritts, Duke University; Phillip Street, Kilpatrick Stockton LLP; Miriam Wilson, SC Launch